Now livetag icon
AI created more apps than ever, but 75% won't make it. Find out how to win. Download the reportbanner icon
CV Therapeutics

May 2026

CV Therapeutics Market Share Analysis for May 2026

Industry: N/A
Domaincvt.com
Year Founded1991
Employees201 - 500
Annual Revenue--
cvt.com
CV Therapeutics
CV Therapeutics (including company regionals)
  • cvt.com
    cvt.com
See more website traffic and engagement information

Total visits to CV Therapeutics's top domains

Understand CV Therapeutics market share and potential market reach.

Total visits last 3 months

No Data to Display

No Data to Display

Avg. visit duration in CV Therapeutics's top domains

Analyze CV Therapeutics engagement metrics.

Average visit duration last 3 months

No Data to Display

No Data to Display

Avg. pageviews on CV Therapeutics's top domains

See how CV Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

No Data to Display

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.


CV Therapeutics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Benchmark Your Digital Performance

Identify high-value opportunities, track your performance, and win your market.


Top technologies used by CV Therapeutics

These are the website technologies, by industry, used by CV Therapeutics top domains

Email Services (1)

Microsoft Exchange Online

Microsoft Exchange Online

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from CV Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsGilead Sciences acquired CV Therapeutics for $1.4B on Jan 1st '09.After Gilead acquired CV Therapeutics in 2009, he stayed on as a Senior Advisor until 2019.

See all CV Therapeutics signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.